BindingDB logo
myBDB logout

BDBM50466900 CHEMBL4277076

SMILES: Cn1cc(C2CCN(CC2)C(=O)C2CCCC2)c2cc(NC(=O)c3ccccc3)ccc12

InChI Key: InChIKey=HDODSTJVQWRICU-UHFFFAOYSA-N

Data: 4 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50466900   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Nuclear receptor ROR-beta


(Homo sapiens (Human))
BDBM50466900
PNG
(CHEMBL4277076)
Show SMILES Cn1cc(C2CCN(CC2)C(=O)C2CCCC2)c2cc(NC(=O)c3ccccc3)ccc12
Show InChI InChI=1S/C27H31N3O2/c1-29-18-24(19-13-15-30(16-14-19)27(32)21-9-5-6-10-21)23-17-22(11-12-25(23)29)28-26(31)20-7-3-2-4-8-20/h2-4,7-8,11-12,17-19,21H,5-6,9-10,13-16H2,1H3,(H,28,31)
PDB
MMDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a>3.00E+4n/an/an/an/an/an/a



Karo Bio AB (now Karo Pharma AB)

Curated by ChEMBL


Assay Description
Inverse agonist activity at RORB (unknown origin) assessed as inhibition of biotinylated co-activator SRC1-2 peptide recruitment after 3 hrs by TR-FR...


J Med Chem 61: 10415-10439 (2018)


Article DOI: 10.1021/acs.jmedchem.8b00392
BindingDB Entry DOI: 10.7270/Q27P922T
More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM50466900
PNG
(CHEMBL4277076)
Show SMILES Cn1cc(C2CCN(CC2)C(=O)C2CCCC2)c2cc(NC(=O)c3ccccc3)ccc12
Show InChI InChI=1S/C27H31N3O2/c1-29-18-24(19-13-15-30(16-14-19)27(32)21-9-5-6-10-21)23-17-22(11-12-25(23)29)28-26(31)20-7-3-2-4-8-20/h2-4,7-8,11-12,17-19,21H,5-6,9-10,13-16H2,1H3,(H,28,31)
PDB

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 56n/an/an/an/an/an/a



Karo Bio AB (now Karo Pharma AB)

Curated by ChEMBL


Assay Description
Inverse agonist activity at human N-terminal 6His-tagged-RORC2 LBD (259 to 483 residues) expressed in Escherichia coli (DE3) cells assessed as inhibi...


J Med Chem 61: 10415-10439 (2018)


Article DOI: 10.1021/acs.jmedchem.8b00392
BindingDB Entry DOI: 10.7270/Q27P922T
More data for this
Ligand-Target Pair
Nuclear receptor ROR-alpha


(Homo sapiens (Human))
BDBM50466900
PNG
(CHEMBL4277076)
Show SMILES Cn1cc(C2CCN(CC2)C(=O)C2CCCC2)c2cc(NC(=O)c3ccccc3)ccc12
Show InChI InChI=1S/C27H31N3O2/c1-29-18-24(19-13-15-30(16-14-19)27(32)21-9-5-6-10-21)23-17-22(11-12-25(23)29)28-26(31)20-7-3-2-4-8-20/h2-4,7-8,11-12,17-19,21H,5-6,9-10,13-16H2,1H3,(H,28,31)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a>3.00E+4n/an/an/an/an/an/a



Karo Bio AB (now Karo Pharma AB)

Curated by ChEMBL


Assay Description
Inverse agonist activity at RORA (unknown origin) assessed as inhibition of biotinylated co-activator SRC1-2 peptide recruitment after 3 hrs by TR-FR...


J Med Chem 61: 10415-10439 (2018)


Article DOI: 10.1021/acs.jmedchem.8b00392
BindingDB Entry DOI: 10.7270/Q27P922T
More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM50466900
PNG
(CHEMBL4277076)
Show SMILES Cn1cc(C2CCN(CC2)C(=O)C2CCCC2)c2cc(NC(=O)c3ccccc3)ccc12
Show InChI InChI=1S/C27H31N3O2/c1-29-18-24(19-13-15-30(16-14-19)27(32)21-9-5-6-10-21)23-17-22(11-12-25(23)29)28-26(31)20-7-3-2-4-8-20/h2-4,7-8,11-12,17-19,21H,5-6,9-10,13-16H2,1H3,(H,28,31)
PDB

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 880n/an/an/an/an/an/a



Karo Bio AB (now Karo Pharma AB)

Curated by ChEMBL


Assay Description
Inverse agonist activity at RORC2 in human Th17 cells assessed as inhibition of IL17A production after 6 days by sandwich ELISA


J Med Chem 61: 10415-10439 (2018)


Article DOI: 10.1021/acs.jmedchem.8b00392
BindingDB Entry DOI: 10.7270/Q27P922T
More data for this
Ligand-Target Pair